Journal of Maxillofacial and Oral Surgery

, Volume 13, Issue 3, pp 281–285 | Cite as

Matrix Metalloproteinase-9 (MMP-9) Expression in Different Subtypes of Ameloblastoma

  • Rachmitha Anne
  • Ening Krisnuhoni
  • Chusnul Chotimah
  • Benny Sjarief Latief
Research Paper

Abstract

Background

Ameloblastoma is a common benign odontogenic tumor of the jaw with a local invasive and highly destructive behavior and can develop in any age, with peak prevalence in 3rd–4th decade. Ameloblastoma can be divided into six histological types: follicular, plexiform, acanthomatous, desmoplastic, granular, and basal cell. Matrix metalloproteinase-9 (MMP-9) (92-kD gelatinase/type IV collagenases = gelatinase B) is involved in bone resorption by degradation of extracellular matrix and osteoclasts recruitment. Recent studies have found that MMP-9 is expressed by ameloblastoma and has a role in ameloblastoma local invasiveness.

Objective

To analyze MMP-9 expression between different histological types of ameloblastoma.

Material and Method

Forty samples of ameloblastoma were collected through consecutive sampling and the MMP-9 expression was detected using immunohistochemistry.

Result

All samples showed positive MMP-9 expression with moderate to strong intensity. 82.4 % plexiform type and 83.3 % mixed type have strong immunoexpression, significantly different with follicular type with only 36.4 % (P < 0.05).

Conclusion

Ameloblastoma plexiform and mixed type have higher MMP-9 expression than ameloblastoma follicular type. Different MMP-9 expression may contribute in different ameloblastoma biological behavior.

Keywords

Ameloblastoma Histological subtypes MMP-9 Local invasion 

References

  1. 1.
    Neville BW, Damm DD, Allen CM, Bouquot JE (2004) Oral and maxillofacial pathology, 2nd edn. WB Saunders Co., Philadelphia, pp 611–619Google Scholar
  2. 2.
    Gardner DG, Heikinheimo K, Shear M, Philipsen HP, Coleman H (2005) Ameloblastoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D (eds) World Health Organization classification of tumours: pathology and genetics of head and neck tumours. IARC Press, Lyon, pp 296–300Google Scholar
  3. 3.
    Reichart PA, Philipsen HP, Sonner S (1995) Ameloblastoma: biological profile of 3677 cases. Oral Oncol Eur J Cancer 31B:86–99CrossRefGoogle Scholar
  4. 4.
    Gortzak RA, Latief BS, Lekkas C, Slootweg PJ (2006) Growth characteristic of large mandibular ameloblastomas: report of 5 cases with implications for the approach to surgery. Int J Oral Maxillofac Surg 35:691–695PubMedCrossRefGoogle Scholar
  5. 5.
    Rastogi V, Pandilwar PK (2010) Ameloblastoma: an evidence based study. J Maxillofac Oral Surg 9:173–177PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Carlson ER, Marx RE (2006) The ameloblastoma: primary, curative surgical management. J Oral Maxillofac Surg 64:484–494PubMedCrossRefGoogle Scholar
  7. 7.
    Ghandhi D, Ayoub AF, Pogrel MA, MacDonald G, Brocklebank LM, Moos KF (2006) Ameloblastoma: a surgeon’s dilemma. J Oral Maxillofac Surg 64:1010–1014PubMedCrossRefGoogle Scholar
  8. 8.
    Pinheiro JJV, Freitas VM, Moretti AIS, Jorge AG, Jaeger RG (2004) Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology 45:65–72PubMedCrossRefGoogle Scholar
  9. 9.
    Stankovic S, Konjevic G, Gopcevic K, Jovic K, Inic M, Jurisic V (2010) Activity of MMP-2 and MMP-9 in sera of breast cancer patients. Pathol Res Pract 206:241–247PubMedCrossRefGoogle Scholar
  10. 10.
    Andersen TL, del Carmen Ovejero M, Kirkegaard T, Lenhard T, Foged NT, Delaisse JM (2004) A scruntiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for presence of MMPs synthesized by other cells. Bone 35:1107–1119PubMedCrossRefGoogle Scholar
  11. 11.
    Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M (1995) Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenases = gelatinase B) in osteoclasts: implications for bone resorption. Lab Investig 72:311–322PubMedGoogle Scholar
  12. 12.
    Zhong M, Li ZJ, Wang J, Yue YL, Bao G (2004) The study of the invasive biologic behavior of ameloblastoma. Zhonghua Kou Qiang Yi Xue Za Zhi 39:45–48PubMedGoogle Scholar
  13. 13.
    Shen LC, Chen YK, Hsue SS, Shaw SY (2010) Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma. J Oral Pathol Med 39:242–249PubMedCrossRefGoogle Scholar
  14. 14.
    Qian Y, Huang H (2010) The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma. J Oral Pathol Med 39:592–598PubMedCrossRefGoogle Scholar
  15. 15.
    Mendenhall WM, Wearning JW, Fernandes R, Malyapa RS, Mendenhall NP (2007) Ameloblastoma. Am J Clin Oncol 30:645–648PubMedCrossRefGoogle Scholar
  16. 16.
    Wilson TJ, Singh RK (2008) Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases. Biochem Biophysic Act 1785:85–95Google Scholar
  17. 17.
    Vicente JC, Fresno MF, Villalain L, Vega JA, Hernandez-Vallejo G (2005) Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 41:283–293PubMedCrossRefGoogle Scholar
  18. 18.
    Ruokolainen H, Paakko P, Turpeenniemi-Hujanen T (2004) Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis. Clin Cancer Res 10:3110–3116PubMedCrossRefGoogle Scholar
  19. 19.
    Jordan RC, Macabeo-Ong M, Shiboski CH, Dekker N, Ginzinger DG, Wong DT, Schmidt BL (2004) Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res 10:6460–6465PubMedCrossRefGoogle Scholar
  20. 20.
    Siqueira AS, Carvalho MRD, Monteiro ACD, Freitas VM, Jaeger RG, Pinheiro JJV (2010) Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behavior. Histopathology 57:128–137PubMedCrossRefGoogle Scholar
  21. 21.
    Ribeiro BF, Iglesias DPP, Nascimento GJF, Galvao HC, Medeiros AMC (2009) Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor. Oral Dis 15:472–477PubMedCrossRefGoogle Scholar
  22. 22.
    Henriques ACG, Vasconcelos MG, Galvao HC, de Souza LB, Freitas R (2011) Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:468–475PubMedCrossRefGoogle Scholar
  23. 23.
    Silveira EJD, Piva MR, Galvao HC, Souza LB, Freitas RA (2007) Role of matrix metalloproteinases in the etiopathogeny of odontogenic cyst. J Bras Patol Med Lab 43:203–209CrossRefGoogle Scholar
  24. 24.
    Kumamoto H, Yamauchi K, Yoshida M, Ooya K (2003) Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas. J Oral Pathol Med 32:114–120PubMedCrossRefGoogle Scholar
  25. 25.
    Yoon H, Jo B, Shin W, Cho Y, Lee J, Hong S, Hong S (2011) Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:767–776PubMedCrossRefGoogle Scholar

Copyright information

© Association of Oral and Maxillofacial Surgeons of India 2013

Authors and Affiliations

  • Rachmitha Anne
    • 1
  • Ening Krisnuhoni
    • 2
  • Chusnul Chotimah
    • 1
  • Benny Sjarief Latief
    • 1
  1. 1.Department of Oral and Maxillofacial Surgery, Faculty of DentistryUniversity of IndonesiaJakarta PusatIndonesia
  2. 2.Department of Pathological Anatomy, Faculty of MedicineUniversity of Indonesia Jakarta PusatIndonesia

Personalised recommendations